Search
Pleconaril
go.drugbank.com/drugs/DB05105InvestigationalIt acts by inhibiting viral replication. The use of pleconaril has not gained approval by the U.S. … Food and Drug Administration (FDA) due to the fact that it has been found to induce CYP3A enzyme activity, therefore increasing the risk for serious drug interactions.
Filgotinib
go.drugbank.com/drugs/DB14845ApprovedInvestigational[A189165] New therapeutic developments target other inflammatory pathways implicated in RA including the Janus kinase (JAK) signaling pathway as seen with filgotinib. … [A189165] Non-selective JAK inhibitors like [tofacitinib] target JAK1 and JAK3 subtypes with minimal activity at JAK2. In contrast, the newly approved filgotinib is a highly selective JAK1 inhibitor.
Artemisia tridentata pollen
go.drugbank.com/drugs/DB10390ApprovedArtemisia tridentata pollen is the pollen of the Artemisia tridentata plant. Artemisia tridentata pollen is mainly used in allergenic testing.
Mixtures: Treatment Set TS128872Bithionol
go.drugbank.com/drugs/DB04813ApprovedWithdrawnBithionol, formerly marketed as an active ingredient in various topical drug products, was shown to be a potent photosensitizer with the potential to cause serious skin disorders.
Madecassoside
go.drugbank.com/drugs/DB15532InvestigationalMixtures: Dr.Different CICA Metal Calming Pad3-Methylfentanyl
go.drugbank.com/drugs/DB01571ExperimentalIllicitinitially discovered in 1974 and widespread illegal use of this drug has occurred since this time. … potent opioid, fentanyl. 3-Methylfentanyl is one of the most powerful opioid drugs sold illegally and is estimated to be between 400-6000 times more potent than morphine in certain cases. 3-Methylfentanyl was
Rhein
go.drugbank.com/drugs/DB13174ExperimentalIt is known to have hepatoprotective, nephroprotective, anti-cancer, anti-inflammatory, and several other protective effects.
MP4
go.drugbank.com/drugs/DB05313InvestigationalMP4 is a hemoglobin-based oxygen carrier designed to serve as an alternative for blood transfusions. … It is free of harmful vasoactivity and provides targeted oxygen delivery to tissues at risk of oxygen deprivation.
Neisseria meningitidis group W-135 capsular polysaccharide tetanus toxoid conjugate antigen
go.drugbank.com/drugs/DB15683ApprovedInvestigationalPerflubron
go.drugbank.com/drugs/DB05791InvestigationalPerflubron (Oxygent) is being developed as an intravascular oxygen carrier designed to augment oxygen delivery in surgical patients.